PNV India update |
04/03/24 | PRICE SENSITIVE | 280.08KB | Share |
|
PNV Webcast Recording - 1H24 Results |
28/02/24 | | 223.11KB | Share |
|
PNV 1H FY24 Results Presentation |
27/02/24 | PRICE SENSITIVE | 1.12MB | Share |
|
PNV Appendix 4D & 1H FY24 Report |
27/02/24 | PRICE SENSITIVE | 2.12MB | Share |
|
PNV Largest ever single order |
16/02/24 | | 283.13KB | Share |
|
PNV Webcast Details - 1H24 Results |
15/02/24 | | 223.65KB | Share |
|
PNV 1H24 Trading Result (unaudited) |
22/01/24 | PRICE SENSITIVE | 294.82KB | Share |
|
PNV PolyNovo presents at Annual J.P. Morgan Heathcare Conference |
10/01/24 | | 1.34MB | Share |
|
PNV First $A8M sales month and $A9M revenue month |
06/12/23 | PRICE SENSITIVE | 695.89KB | Share |
|
PNV Chairman address to Bell Potter Healthcare Conference |
15/11/23 | | 211.14KB | Share |
|
PNV AGM 2023 - Webcast Recording |
07/11/23 | | 253.98KB | Share |
|
PNV Voting Results - 2023 AGM |
03/11/23 | | 299.08KB | Share |
|
PNV AGM - Chairman and CEO address to shareholders |
03/11/23 | PRICE SENSITIVE | 285.21KB | Share |
|
PNV Director Share Purchase - Robyn Elliott |
03/11/23 | | 274.19KB | Share |
|
PNV PolyNovo presents at Wilsons Drug and Device Conference |
26/10/23 | | 1.46MB | Share |
|
PNV Notice of Meeting - Correction to Directors Bio |
04/10/23 | | 248.43KB | Share |
|
PNV Notice of Meeting |
02/10/23 | | 319.73KB | Share |
|
PNV BARDA increases funding US$10M |
02/10/23 | PRICE SENSITIVE | 297KB | Share |
|
PNV YTD August 2023 Trading Update |
25/09/23 | PRICE SENSITIVE | 302.79KB | Share |
|
PNV Trading Halt |
25/09/23 | PRICE SENSITIVE | 138.1KB | Share |
|
PNV Annual Report 2023 |
13/09/23 | | 5.1MB | Share |
|
PNV PolyNovo presents at Evans & Partners Healthcare Conference |
12/09/23 | | 1.46MB | Share |
|
PNV Webcast Recording - FY23 Results |
31/08/23 | | 240.4KB | Share |
|
PNV Corporate Governance Statement |
24/08/23 | | 163.64KB | Share |
|
PNV Appendix 4G |
24/08/23 | | 291.17KB | Share |
|
PNV FY23 Results Presentation |
23/08/23 | PRICE SENSITIVE | 769.19KB | Share |
|
PNV Appendix 4E and FY23 Financial Statements |
23/08/23 | PRICE SENSITIVE | 1.94MB | Share |
|
PNV Webcast Details - FY23 Results |
11/08/23 | | 235.43KB | Share |
|
PNV Appendix 3Y - Robyn Elliott |
30/06/23 | | 273.9KB | Share |
|
PNV Director Share Purchase - David Williams |
08/06/23 | | 259.9KB | Share |
|
PNV Director Share Purchase - David Williams |
08/06/23 | | 259.82KB | Share |
|
PNV First ever A$7M Sales Month |
07/06/23 | PRICE SENSITIVE | 305.64KB | Share |
|
PNV Trading Halt |
06/06/23 | PRICE SENSITIVE | 256.72KB | Share |
|
PNV Pause in Trading |
06/06/23 | PRICE SENSITIVE | 116.29KB | Share |
|
PNV Notification regarding unquoted securities - PNV |
31/05/23 | | 25.2KB | Share |
|
PNV PolyNovo presents at Macquarie Australia Conference |
03/05/23 | | 989.36KB | Share |
|
PNV NovoSorb MTX First Sales and March 2023 $6m Revenue |
02/05/23 | PRICE SENSITIVE | 310.66KB | Share |
|
PNV Trading Halt |
01/05/23 | PRICE SENSITIVE | 255.28KB | Share |
|
PNV Application for quotation of securities - PNV |
31/03/23 | | 25.17KB | Share |
|
PNV Change of Director's Interest Notice |
23/03/23 | | 414.72KB | Share |
|
PNV Application for quotation of securities - PNV |
16/03/23 | | 25.18KB | Share |
|
PNV S&P DJI Announces March 2023 Quarterly Rebalance |
03/03/23 | PRICE SENSITIVE | 128.97KB | Share |
|
PNV 1H FY23 Results - Webcast Recording |
01/03/23 | | 241.51KB | Share |
|
PNV PolyNovo presents at Macquarie Bank |
24/02/23 | | 402.69KB | Share |
|
PNV 1H FY23 Results Presentation |
23/02/23 | PRICE SENSITIVE | 559.68KB | Share |
|
PNV Appendix 4D and 1H FY23 Report |
23/02/23 | PRICE SENSITIVE | 4.01MB | Share |
|
PNV Appendix 3Y - Robyn Elliott |
22/02/23 | | 273.72KB | Share |
|
PNV Appendix 3Y - Christine Emmanuel |
22/02/23 | | 274.75KB | Share |
|
PNV Appendix 3Y - Andrew Lumsden |
22/02/23 | | 274.79KB | Share |
|
PNV Appendix 3Y - Bruce Rathie |
22/02/23 | | 274.47KB | Share |
|
PNV Appendix 3Y - David Williams |
22/02/23 | | 260.06KB | Share |
|
PNV Cleansing Notice |
16/02/23 | | 192.49KB | Share |
|
PNV Application for quotation of securities - PNV |
15/02/23 | | 23.12KB | Share |
|
PNV Update - SynPath Diabetic Foot Ulcer Trial |
15/02/23 | | 170.87KB | Share |
|
PNV Webcast details - 1HFY23 Results |
14/02/23 | | 152.4KB | Share |
|
PNV Results of General Meeting |
17/01/23 | | 294.85KB | Share |
|
PNV 1H23 Indicative Trading Result (unaudited) |
16/01/23 | PRICE SENSITIVE | 301.28KB | Share |
|
PNV Presentation slides - J.P. Morgan Healthcare Conference |
11/01/23 | | 1.36MB | Share |
|
PNV Presentation to J.P. Morgan Healthcare Conference |
10/01/23 | | 236.29KB | Share |
|
PNV Application for quotation of securities - PNV |
19/12/22 | | 23.33KB | Share |
|
PNV Successful Completion of Share Purchase Plan |
16/12/22 | PRICE SENSITIVE | 297.22KB | Share |
|
PNV Webcast Recording - Investor Presentation and Update |
07/12/22 | | 212.84KB | Share |
|
PNV Notice of General Meeting |
07/12/22 | | 325.11KB | Share |
|
PNV Webcast Agenda - Investor Presentation and Update |
05/12/22 | | 361.4KB | Share |
|
PNV Amended Weblink - Investor Presentation & Update 5 Dec 2022 |
02/12/22 | | 266.43KB | Share |
|
PNV Investor Presentation & Update - Webcast 5 Dec 2022 |
02/12/22 | | 266.4KB | Share |
|
PNV Share Purchase Plan (SPP) Offer |
30/11/22 | PRICE SENSITIVE | 475.6KB | Share |
|
PNV Cleansing Notice |
29/11/22 | | 192.7KB | Share |
|
PNV Application for quotation of securities - PNV |
28/11/22 | | 23.53KB | Share |
|
PNV Ceasing to be a substantial holder |
23/11/22 | | 699.79KB | Share |
|
PNV Completion of $30m Institutional Placement |
23/11/22 | PRICE SENSITIVE | 320.5KB | Share |
|
PNV Proposed issue of securities - PNV |
22/11/22 | | 35.24KB | Share |
|
PNV Investor Presentation |
22/11/22 | PRICE SENSITIVE | 1.31MB | Share |
|
PNV Capital Raising |
22/11/22 | PRICE SENSITIVE | 218.48KB | Share |
|
PNV Trading Halt |
22/11/22 | PRICE SENSITIVE | 256.24KB | Share |
|
PNV Chairman's address at Bell Potter Healthcare Conference |
10/11/22 | | 332.21KB | Share |
|
PNV PolyNovo enters India market |
07/11/22 | | 301.25KB | Share |
|
PNV AGM 2022 - Webcast Recording |
04/11/22 | | 238.38KB | Share |
|
PNV Results of 2022 Annual General Meeting |
28/10/22 | | 306.22KB | Share |
|
PNV Chairman and CEO - AGM address to shareholders |
28/10/22 | PRICE SENSITIVE | 326.28KB | Share |
|
PNV Hong Kong - Two cases, Two surgeons |
26/10/22 | | 297.13KB | Share |
|
PNV Canada - NovoSorb BTM registration approved |
25/10/22 | | 295.69KB | Share |
|
PNV Director Share Purchase - David Williams |
17/10/22 | | 180.31KB | Share |
|
PNV Director Share Purchase - David Williams |
14/10/22 | | 180.34KB | Share |
|
PNV Director Share Purchase - David Williams |
13/10/22 | | 180.25KB | Share |
|
PNV Director Share Purchase - David Williams |
11/10/22 | | 180.29KB | Share |
|
PNV Director Share Purchase - David Williams |
10/10/22 | | 180.26KB | Share |
|
PNV Q1 FY23 Sales Result |
06/10/22 | PRICE SENSITIVE | 303.55KB | Share |
|
PNV Notice of Annual General Meeting |
27/09/22 | | 405.38KB | Share |
|
PNV Annual Report 2022 |
21/09/22 | | 6.57MB | Share |
|
PNV Becoming a substantial holder |
21/09/22 | | 900.9KB | Share |
|
PNV FDA 510(k) clearance for NovoSorb MTX |
19/09/22 | PRICE SENSITIVE | 185.25KB | Share |
|
PNV Trading halt |
16/09/22 | PRICE SENSITIVE | 142.63KB | Share |
|
PNV Pause in trading |
16/09/22 | PRICE SENSITIVE | 115.9KB | Share |
|
PNV Final Director's Interest Notice |
07/09/22 | | 243.73KB | Share |
|
PNV Director resignation & appointment Chief Tech & Sci Officer |
01/09/22 | | 277.47KB | Share |
|
PNV PolyNovo FY22 Briefing Session |
26/08/22 | PRICE SENSITIVE | 377.09KB | Share |
|
PNV Corporate Governance Statement |
26/08/22 | | 162.52KB | Share |
|
PNV Appendix 4G |
26/08/22 | | 291.36KB | Share |
|
PNV FY22 Results Presentation |
26/08/22 | PRICE SENSITIVE | 878.58KB | Share |